Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome (Q84970745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Gaku Yamanaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hisashi Kawashima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Shingo Oana

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yu Ishida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Tasuku Miyajima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yasuyo Kashiwagi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Akinori Hoshika

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20807663

4 July 2024

publication date

1 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

15 November 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20807663

full work available at URL

4 July 2024

https://api.elsevier.com/content/article/PII:S0022510X10003412?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

https://api.elsevier.com/content/article/PII:S0022510X10003412?httpAccept=text/plain

4 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Journal of the Neurological Sciences

4 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

106-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice

13 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Cerebrospinal fluid Diacron-Reactive Oxygen Metabolite levels in pediatric patients with central nervous system diseases

4 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy

4 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production

4 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures

4 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Increased plasma levels of cytokines after seizures in localization-related epilepsy

4 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder

4 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures

4 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

The IL-1beta system in epilepsy-associated malformations of cortical development

4 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy

4 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Serum cytokine levels are altered in patients with West syndrome

4 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Immunologic aspects of West syndrome and evidence of plasma inhibitory effects on T cell function

4 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Cerebrospinal fluid interleukin-6 levels in patients with West syndrome

4 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome

4 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome

4 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

A Prospective Study of Infantile Spasms: Clinical and Therapeutic Correlations

4 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Remission associated with human herpesvirus infection in west syndrome.

4 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: A video-EEG study.

4 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?

4 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and beta-endorphin

4 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.07.018

4 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807663%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference